Computational Analysis of Human Immunodeficiency Virus (HIV) Type-1 Reverse Transcriptase Crystallographic Models Based on Significant Conserved Residues Found in Highly Active Antiretroviral Therapy (HAART)-Treated Patients (Supplementary Material)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|4|290-308

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.4, 2010-02, pp. : 290-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E.   Paterson Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite

Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection

By  

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 13-22

Bentham Science Publishers

Access to resources Recommend Favorite

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite

Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 62-72

Bentham Science Publishers

Access to resources Recommend Favorite